fda pulls tirzepatide 🚨 Moves to Shut Down Mass-Market Compounded GLP-1s The FDA is taking action to restrict widely marketed, non–FDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand FDA says shortage of GLP-1

If you are traveling with tirzepatide , insulated transport containers are non-negotiable

Tirzepatide, a dual GLP-1 and GIP receptor agonist, works faster than older single-agent medications because it targets two hunger pathways simultaneously

@mcneese.chad Wasnt sure where this should go so move it if it makes sense

Up to 25% body weight loss The SURMOUNT clinical trials demonstrated that tirzepatide therapy not only improved glucose levels but also had a substantial impact on body weight reduction

What does CJC-1295 do in the GH release peptide stack

Collectively, these data suggest obesity engenders an immunosuppressive tumor environment that enriches for a population of ineffective, non-activated CD8+ TILs, and that this immunosuppressed phenotype is partially reversed with chronic tirzepatide treatment